Clinical and Psychosocial Factors Influencing Retinal Screening Uptake Among Young Adults with Type 2 Diabetes
Purpose of Review
Young adults with type 2 diabetes (T2D, 18–39 years) experience early-onset and rapid progression of diabetic retinopathy (DR), the leading cause of vision loss for working age adults. Despite this, uptake of retinal screening, the crucial first step in preventing vision loss from DR, is low. The aim of this review is to summarize the clinical and psychosocial factors affecting uptake of retinal screening.
Barriers include lack of diabetes-related symptoms, low personal DR risk perception, high rates of depression and diabetes-related distress, fatalism about inevitability of complications, time and financial constraints, disengagement with existing diabetes self-management services, and perceived stigma due to having a condition associated with older adults.
Young adults with T2D are an under-researched population who face an accumulation of barriers to retinal screening. Tailored interventions that address the needs, characteristics, and priorities of young adults with T2D are warranted.
KeywordsDiabetic retinopathy Young adults Type 2 diabetes Retinal screening Patient barriers Psychosocial Clinical
Amelia Lake was supported by a Deakin University, School of Psychology Higher Degree Research publication award. Jane Speight is the Foundation Director of the Australian Centre for Behavioural Research in Diabetes, with core funding provided by a collaboration between Diabetes Victoria and Deakin University.
Compliance with Ethical Standards
Conflict of Interest
A. J. Lake, G. Rees, and J. Speight declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
The studies involving human participants, which were conducted by the authors and which are contained in this review, were conducted in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the studies.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.•• Lascar N, Brown J, Pattison H, Barnett AH, Bailey CJ, Bellary S. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 2018;6(1):69–80. https://doi.org/10.1016/s2213-8587(17)30186-9. This paper describes the epidemiology, pathophysiology, socioecological determinants, and clinical and complication characteristics of younger-onset T2D. CrossRefPubMedGoogle Scholar
- 2.Al-Saeed AH, Constantino MI, Molyneaux L, D’Souza M, Limacher-Gisler F, Luo C, et al. An inverse relationship between age of type 2 diabetes onset and complication risk and mortality: the impact of youth-onset type 2 diabetes. Diabetes Care. 2016;39:823–9. https://doi.org/10.2337/dc15-0991.CrossRefPubMedGoogle Scholar
- 3.Leasher JL, Bourne RAA, Flaxman SR, Jonas JB, Keeffe J, Naidoo K, et al. Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 1990 to 2010. Diabetes Care. 2016;39:1643–9. https://doi.org/10.2337/dc15-2171/-/DC1.CrossRefPubMedGoogle Scholar
- 6.Agardh E, Agardh CD, Hansson-Lundblad C. The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy. Diabet Med. 1993;10(6):555–9. https://doi.org/10.1111/j.1464-5491.1993.tb00120.x.CrossRefPubMedGoogle Scholar
- 7.Arun CS, Ngugi N, Lovelock L, Taylor R. Effectiveness of screening in preventing blindness due to diabetic retinopathy. Diabet Med. 2003;20(3):186–90. https://doi.org/10.1046/j.1464-5491.2003.t01-1-00899.x.CrossRefPubMedGoogle Scholar
- 11.Mitchell P, Foran S. Guidelines for the management of diabetic retinopathy. National Health and Medical Research Council, Commonwealth of Australia. 2008. https://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/di15.pdf. Accessed 22 Aug 2017.
- 13.National Institute for health and Care Excellence. Type 2 diabetes in adults: management NICE guideline [NG28]. 2015. https://www.nice.org.uk/guidance/ng28/chapter/1-Recommendations#managing-complications. Accessed 22 Aug 2017.
- 15.•• Scanlon PH, Stratton IM, Leese GP, Bachmann MO, Land M, Jones C, et al. Screening attendance, age group and diabetic retinopathy level at first screen. Diabetic Medicine. 2016;33(7):904–11. https://doi.org/10.1111/dme.12957. This paper demonstrates the considerable delay in retinal screening uptake for young adults with T2D and links time to first screen with rate of vision-threatening retinopathy. CrossRefPubMedGoogle Scholar
- 19.Villarroel MA, Vahratian A, Ward BW. Health care utilization among U.S. adults with diagnosed diabetes, 2013. In: National Centre for Health Statistics Data Brief. US Department of Health and Human Services. 2015. www.cdc.gov/nchs/data/databriefs/db183.pdf. Accessed 22 Aug 2017.
- 21.Sachdeva A, Stratton IM, Unwin J, Moreton R, Scanlon PH. Diabetic retinopathy screening: study to determine risk factors for non-attendance. Diabetes Primary Care. 2012;14(5):308–16.Google Scholar
- 22.• Kashim R, Ojo O, Newton P. Diabetic retinopathy screening: a systematic review on patients’ non-attendance. Int J Environ Res Public Health. 2017;15:157–69. https://doi.org/10.3390/ijerph15010157. The first systematic review of patient and system-level barriers and facilitators to patients’ non-attendance to retinal screening. CrossRefGoogle Scholar
- 24.Song SH. Emerging type 2 diabetes in young adults. In: Ahmad SI, editor. Diabetes: an old disease, a new insight. New York: Springer Science; 2012.Google Scholar
- 25.• Bo A, Thomsen RW, Nielsen JS, Nicolaisen SK, Beck-Nielsen H, Rungby J et al. Early-onset type 2 diabetes: age gradient in clinical and behavioural risk factors in 5115 persons with newly diagnosed type 2 diabetes—results from the DD2 study. Diabetes/Metab Res Rev. 2017:n/a-n/a. https://doi.org/10.1002/dmrr.2968. This paper summarizes clinical and behavioral risk factors for people diagnosed with T2D before aged 45 years compared with older age at diagnosis groupings (46–55 years, 56–65 years, 66–75 years, and > 75 years).
- 29.• Liu Y, Swearingen R. Diabetic eye screening: knowledge and perspectives from providers and patients. Curr Diab Rep. 2017;17(10):94. https://doi.org/10.1007/s11892-017-0911-2. A summary of primary care providers’ and patients’ perspectives of retinal screening. This summary highlights the crucial role of proactive care coordination and the opportunity provided by advances in teleophthalmology in improving retinal screening uptake. CrossRefPubMedGoogle Scholar
- 30.Hipwell AE, Sturt J, Lindenmeyer A, Stratton I, Gadsby R, O'Hare PO, et al. Attitudes, access and anguish: a qualitative interview study of staff and patients’ experiences of diabetic retinopathy screening. BMJ Open. 2014;4(12):e005498. https://doi.org/10.1136/bmjopen-2014-005498.CrossRefPubMedPubMedCentralGoogle Scholar
- 35.Al-Alawi A, Al-Hassan A, Chauhan D, Al-Futais M, Khandekar R. Knowledge, attitude, and perception of barriers for eye care among diabetic persons registered at employee health department of a Tertiary Eye Hospital of Central Saudi Arabia. Middle East Afr J Ophthalmol. 2016;23(1):71–4. https://doi.org/10.4103/0974-9233.164629.CrossRefPubMedPubMedCentralGoogle Scholar
- 36.Browne JL, Nefs G, Pouwer F, Speight J. Depression, anxiety and self-care behaviours of young adults with type 2 diabetes: results from the International Diabetes Management and Impact for Long-term Empowerment and Success (MILES) Study. Diabet Med. 2014;32(1):133–40. https://doi.org/10.1111/dme.12566.CrossRefPubMedGoogle Scholar
- 38.Crume TL, Hamman RF, Isom S, Talton J, Divers J, Mayer-Davis EJ, et al. Factors influencing time to case registration for youth with type 1 and type 2 diabetes: SEARCH for Diabetes in Youth Study. Ann Epidemiol. 2016;26(9):631–7. https://doi.org/10.1016/j.annepidem.2016.07.014.CrossRefPubMedPubMedCentralGoogle Scholar
- 43.•• Cavan D, Makaroff L, da Rocha FJ, Sylvanowicz M, Ackland P, Conlon J, et al. The Diabetic Retinopathy Barometer Study: global perspectives on access to and experiences of diabetic retinopathy screening and treatment. Diabetes Res Clin Pract. 2017;129:16–24. https://doi.org/10.1016/j.diabres.2017.03.023. This paper provides a global perspective on the experience of DR screening and treatment across 41 countries from both the patient and provider. CrossRefPubMedGoogle Scholar
- 50.• Lake AJ, Browne JL, Abraham C, Tumino D, Hines C, Rees G, et al. A tailored intervention to promote uptake of retinal screening among young adults with type 2 diabetes—an intervention mapping approach. BMC Health Serv Res. in press; This paper reports findings of a comprehensive needs assessment, exploring factors impacting retinal screening for young adults with T2D, including results from a nationwide survey Google Scholar
- 52.Diabetes Australia. Young adults with diabetes needs analysis. Diabetes Australia, Canberra, Canberra. 2006. http://static.diabetesaustralia.com.au/s/fileassets/diabetes-australia/6321f173-1642-42ed-8501-e95dc1ffa189.pdf. Accessed 22 Aug 2017.
- 55.Strutton R, Du Chemin A, Stratton IM, Forster AS. System-level and patient-level explanations for non-attendance at diabetic retinopathy screening in Sutton and Merton (London, UK): a qualitative analysis of a service evaluation. BMJ Open. 2016;6(5):e010952. https://doi.org/10.1136/bmjopen-2015-010952.CrossRefPubMedPubMedCentralGoogle Scholar
- 56.• Lake AJ, Browne JL, Rees G, Speight J. What factors influence uptake of retinal screening among young adults with type 2 diabetes? A qualitative study informed by the Theoretical Domains Framework. J Diabetes Complicat. 2017;31(6):997–1006. https://doi.org/10.1016/j.jdiacomp.2017.02.020. This paper is the first to explore, in-depth, the barriers and facilitators to retinal screening for young adults with T2D. Using an older-adult with T2D comparator group, salient factors were identified. CrossRefPubMedGoogle Scholar
- 59.Silverstein J, Cheng P, Ruedy KJ, Kollman C, Beck RW, Klingensmith GJ, et al. Depressive symptoms in youth with type 1 or type 2 diabetes: results of the Pediatric Diabetes Consortium Screening Assessment of Depression in Diabetes Study. Diabetes Care. 2015;38:2341–3. https://doi.org/10.2337/dc15-0982.CrossRefPubMedGoogle Scholar
- 62.Lindenmeyer A, Sturt J, Hipwell AE, Stratton I, Al-Athamneh N, Gadsby R, et al. Influence of primary care practices on patients’ uptake of diabetic retinopathy screening: a qualitative case study. Br J Gen Pract. 2014;64(625):e484–92. https://doi.org/10.3399/bjgp14X680965.CrossRefPubMedPubMedCentralGoogle Scholar
- 65.Waqar S, Bullen G, Chant S, Salman R, Vaidya B, Ling R. Cost implications, deprivation and geodemographic segmentation analysis of non-attenders (DNA) in an established diabetic retinopathy screening programme. Diabetes Metab Syndr Clin Res Rev. 2012;6(4):199–202. https://doi.org/10.1016/j.dsx.2012.08.009.CrossRefGoogle Scholar
- 67.van Eijk KND, Blom JW, Gussekloo J, Polak BCP, Groeneveld Y. Diabetic retinopathy screening in patients with diabetes mellitus in primary care: incentives and barriers to screening attendance. Diabetes Res Clin Pract. 2012;96(1):10–6. https://doi.org/10.1016/j.diabres.2011.11.003.CrossRefPubMedGoogle Scholar
- 73.Rubin R, Peyrot M. Psychosocial adjustment to diabetes and critical periods of psychological risk. In: Young-Hyman D, Peyrot M, editors. Psychosocial care for people with diabetes: American Diabetes Association; 2012.Google Scholar
- 75.Williams MV, Baker DW, Parker RM, Nurss JR. Relationship of functional health literacy to patients’ knowledge of their chronic disease. Arch Intern Med. 1998;158:7.Google Scholar
- 77.Li R, Sundar S, Lipman R, Burrows N, Kolb LE, Rutledge S. Diabetes self-management education and training among privately insured persons with newly diagnosed diabetes—United States, 2011–2012. Atlanta, GA 2014 November 21 Contract No.: 46.Google Scholar
- 88.Wilson JMG, Jungner G. Principles and practice of screening for disease. In: Public Health Papers No.34. 1968. www.who.int/bulletin/volumes/86/4/07-050112bp.pdf. Accessed 23 Nov 2017.
- 91.Forster AS, Forbes A, Dodhia H, Connor C, Du Chemin A, Sivaprasad S, et al. Changes in detection of retinopathy in type 2 diabetes in the first 4 years of a population-based diabetic eye screening program: retrospective cohort study. Diabetes Care. 2013;36(9):2663–9. https://doi.org/10.2337/dc13-0130.CrossRefPubMedPubMedCentralGoogle Scholar
- 96.Halliday JA, Hendrieckx C, Busija L, Browne JL, Nefs G, Pouwer F, et al. Validation of the WHO-5 as a first-step screening instrument for depression in adults with diabetes: results from diabetes MILES—Australia. Diabetes Res Clin Pract. 2017;132:27–35. https://doi.org/10.1016/j.diabres.2017.07.005.CrossRefPubMedGoogle Scholar
- 99.Hendrieckx C, Halliday JA, Beeney LJ, Speight J. Diabetes and emotional health : a handbook for health professionals supporting adults with type 1 or type 2 diabetes. Australian Centre for Behavioural Research in Diabetes Melbourne 2016. https://nla.gov.au/anbd.bib-an58852017. Accessed 12 Apr 2018.